ATOVAQUONE Side Effects

6710656-6 | Diarrhoea
on May 04, 2010 Male patient from UNITED STATES , 69 years of age, weighting 127.2 lb, was treated with Atovaquone (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea. Atovaquone dosage: 750 Mg Bid Po. Patient was hospitalized.

6609294-5 | Multi-organ Failure, Pyrexia
Patient was taking Atovaquone (View Usage). Patient had the following side effects: multi-organ failure, pyrexia on Feb 15, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with babesiosis and. Atovaquone dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6609293-3 | Anaemia, Asthenia, Chills, Decreased Appetite, Hyperhidrosis, Pathogen Resistance, Pyrexia
Adverse event was reported on Feb 15, 2010 by a Female patient taking Atovaquone (View Usage) (Dosage: 750 / Twice Per Day / Unknwon) was diagnosed with babesiosis and. Location: UNITED STATES , 86 years of age, After Atovaquone was administered, patient had the following side effects: anaemia, asthenia, chills, decreased appetite, hyperhidrosis, pathogen resistance, pyrexia. Patient was hospitalized.

6163186-7 | Abdominal Pain Lower, Constipation, Diarrhoea, Haematochezia
on Apr 20, 2009 Male patient from UNITED STATES , 34 years of age, weighting 129.0 lb, was diagnosed with upper respiratory tract infection, antifungal prophylaxis and was treated with Atovaquone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, constipation (What is constipation?), diarrhoea, haematochezia. Atovaquone dosage: 1 Ml Bid Po. During the same period patient was treated with AZITHROMYCIN (2 Tab Qweek Po) (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.


6035392-3 | Abdominal Pain, Chest Pain, Lip Swelling, Nausea, Salivary Hypersecretion, Systemic Inflammatory Response Syndrome
on Jan 12, 2009 Female patient from UNITED STATES , weighting 134.7 lb, was diagnosed with antifungal prophylaxis and was treated with Atovaquone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), chest pain (What is chest pain?), lip swelling, nausea (What is nausea?), salivary hypersecretion, systemic inflammatory response syndrome. Atovaquone dosage: 750 Mg/5 Ml 1500 Mg Daily Oral. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), TRUVADA (View Truvada Review and Truvada Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), VALTREX (View Valtrex Review and Valtrex Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6002997-5 | Activated Partial Thromboplastin Time Prolonged, Brain Oedema, Cerebral Haemorrhage, Cerebral Toxoplasmosis, Coma, Convulsion, Headache
Patient was taking Atovaquone (View Usage). After Atovaquone was administered, patient had the following side effects: activated partial thromboplastin time prolonged, brain oedema, cerebral haemorrhage, cerebral toxoplasmosis, coma, convulsion, headache (What is headache?) on Dec 01, 2008 from ISRAEL Additional patient health information: Female patient , child 12 years of age, was diagnosed with antifungal prophylaxis and. Atovaquone dosage: 1200 Mg / Per Day / Oral. During the same period patient was treated with DAPSONE (75 Mg / Per Day / Oral) (View Dapsone Review and Dapsone Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ). Patient was hospitalized.

5268440-9 | Fatigue
Adverse event was reported on Mar 08, 2007 by a Male patient taking Atovaquone (View Usage) (Dosage: 10mg Twice Per Day) was diagnosed with prophylaxis and. Location: UNITED KINGDOM , 42 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: fatigue.

5162465-X | Jaundice, Liver Function Test Abnormal
on Nov 29, 2006 Female patient from UNITED STATES , weighting 156.0 lb, was diagnosed with pneumocystis jiroveci pneumonia, prophylaxis and was treated with Atovaquone (View Usage). Patient had the following side effects: jaundice (What is jaundice?), liver function test abnormal. Atovaquone dosage: 1 Tsp Bid Po.

4842581-X | Asthenia, Rash Macular, Stevens-johnson Syndrome
on Oct 24, 2005 Male patient from CANADA , 33 years of age, was diagnosed with antibiotic prophylaxis, oedema and was treated with Atovaquone (View Usage). After Atovaquone was administered, patient had the following side effects: asthenia, rash macular, stevens-johnson syndrome. Atovaquone dosage: 1500mg Twice Per Day. During the same period patient was treated with SEPTRA SS (1tab Per Day) (View Septra Ss Review and Septra Ss Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

4724359-0 | Erythema Multiforme
Patient was taking Atovaquone (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme on Jul 20, 2005 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 159.0 lb, was diagnosed with pneumocystis jiroveci pneumonia, prophylaxis, candidiasis and. Atovaquone dosage: 1500 Mg Po Qd. During the same period patient was treated with FLUCONAZOLE (100 Mg Po Q 8) (View Fluconazole Review and Fluconazole Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ).